These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 11604031)

  • 21. Pharmacophore features of potential drugs.
    Muegge I
    Chemistry; 2002 May; 8(9):1976-81. PubMed ID: 11981881
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Automated selection of compounds with physicochemical properties to maximize bioavailability and druglikeness.
    Oashi T; Ringer AL; Raman EP; Mackerell AD
    J Chem Inf Model; 2011 Jan; 51(1):148-58. PubMed ID: 21142079
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characteristic physical properties and structural fragments of marketed oral drugs.
    Vieth M; Siegel MG; Higgs RE; Watson IA; Robertson DH; Savin KA; Durst GL; Hipskind PA
    J Med Chem; 2004 Jan; 47(1):224-32. PubMed ID: 14695836
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Library design practices for success in lead generation with small molecule libraries.
    Goodnow RA; Guba W; Haap W
    Comb Chem High Throughput Screen; 2003 Nov; 6(7):649-60. PubMed ID: 14683492
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The physicochemical challenges of designing multiple ligands.
    Morphy R; Rankovic Z
    J Med Chem; 2006 Aug; 49(16):4961-70. PubMed ID: 16884308
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pursuing the leadlikeness concept in pharmaceutical research.
    Hann MM; Oprea TI
    Curr Opin Chem Biol; 2004 Jun; 8(3):255-63. PubMed ID: 15183323
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Strategy of molecular design of drugs: the unification of macro-properties and micro-structures of a molecule].
    Guo ZR
    Yao Xue Xue Bao; 2008 Mar; 43(3):227-33. PubMed ID: 18630256
    [TBL] [Abstract][Full Text] [Related]  

  • 28. ADME evaluation in drug discovery. 3. Modeling blood-brain barrier partitioning using simple molecular descriptors.
    Hou TJ; Xu XJ
    J Chem Inf Comput Sci; 2003; 43(6):2137-52. PubMed ID: 14632466
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Similarity measures for rational set selection and analysis of combinatorial libraries: the Diverse Property-Derived (DPD) approach.
    Lewis RA; Mason JS; McLay IM
    J Chem Inf Comput Sci; 1997; 37(3):599-614. PubMed ID: 9177003
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular complexity and its impact on the probability of finding leads for drug discovery.
    Hann MM; Leach AR; Harper G
    J Chem Inf Comput Sci; 2001; 41(3):856-64. PubMed ID: 11410068
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fragment-based drug discovery: what has it achieved so far?
    Alex AA; Flocco MM
    Curr Top Med Chem; 2007; 7(16):1544-67. PubMed ID: 17979767
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diverse viewpoints on computational aspects of molecular diversity.
    Martin YC
    J Comb Chem; 2001; 3(3):231-50. PubMed ID: 11350246
    [No Abstract]   [Full Text] [Related]  

  • 33. A new rapid and effective chemistry space filter in recognizing a druglike database.
    Zheng S; Luo X; Chen G; Zhu W; Shen J; Chen K; Jiang H
    J Chem Inf Model; 2005; 45(4):856-62. PubMed ID: 16045278
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An integrated drug-likeness study for bicyclic privileged structures: from physicochemical properties to in vitro ADME properties.
    Han C; Zhang J; Zheng M; Xiao Y; Li Y; Liu G
    Mol Divers; 2011 Nov; 15(4):857-76. PubMed ID: 21538133
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oriented substituent pharmacophore PRopErtY space (OSPPREYS): a substituent-based calculation that describes combinatorial library products better than the corresponding product-based calculation.
    Martin EJ; Hoeffel TJ
    J Mol Graph Model; 2000; 18(4-5):383-403. PubMed ID: 11143557
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacophore mapping and in silico screening to identify new potent leads for A(2A) adenosine receptor as antagonists.
    Mustyala KK; Chitturi AR; Naikal James PS; Vuruputuri U
    J Recept Signal Transduct Res; 2012 Apr; 32(2):102-13. PubMed ID: 22384789
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Modern Computational Strategies for Designing Drugs to Curb Human Diseases: A Prospect.
    Dar KB; Bhat AH; Amin S; Hamid R; Anees S; Anjum S; Reshi BA; Zargar MA; Masood A; Ganie SA
    Curr Top Med Chem; 2018; 18(31):2702-2719. PubMed ID: 30659543
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Selecting the right compounds for screening: does Lipinski's Rule of 5 for pharmaceuticals apply to agrochemicals?
    Tice CM
    Pest Manag Sci; 2001 Jan; 57(1):3-16. PubMed ID: 11455629
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Physicochemical Profiles of the Marketed Agrochemicals and Clues for Agrochemical Lead Discovery and Screening Library Development.
    Rao H; Huangfu C; Wang Y; Wang X; Tang T; Zeng X; Li Z; Chen Y
    Mol Inform; 2015 May; 34(5):331-8. PubMed ID: 27490277
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacophore identification, in silico screening, and virtual library design for inhibitors of the human factor Xa.
    Krovat EM; Frühwirth KH; Langer T
    J Chem Inf Model; 2005; 45(1):146-59. PubMed ID: 15667140
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.